Clay Siegall co-founded the Seattle Company in 1998. He is the president of the company. It is through his leadership that several cancer therapies such as Adcetris was approved in 2011. In 2001, Siegall managed to collect over $675 to give a foundation to Seattle Genetics. He did this through public and private funding. Clay graduated with a Ph.D. in Genetics from George Washington University and a Bachelor’s degree in Zoology from Maryland University.
Seattle Genetics has not only come up with some cancer remedies but also ensured that there are antibody technologies. Clay has always had a passion for helping patients. The Adcetris, which was approved in 2011 as a therapy for cancer has currently been approved in 65 countries. More than 20 ADCs in clinical developments are already using the products of Seattle Genetics. Bristol Myers was the company Siegall served at before co-founding the Seattle and becoming its president. He worked in Bristol Myers from 1991 to 1997.
Clay Siegall’s Achievements
Dr. Siegall has received some awards. In 2013, he received an award for computer, math and natural sciences. In 2012, he received the Pacific North-West Ernst and Young Entrepreneur of the year. Clay has 70 publications and more than 50 patents. Clay Siegall passion for cancer did not just happen. He observed how it ate up his father from when he was nine years old until his death when he was 24 years old. His primary focus at the time when he founded Seattle Genetics was to help patients.
Clay also advised young entrepreneurs that to seek knowledge because no one is the custodian of knowledge. However, to be successful, one needed to interact with smart people to understand how to keep focus when you finally get into the business. Siegall views the success of Seattle Genetics as being able to partner with other industry leaders in drug development. These leaders have also helped Siegall grow his resources into new ideas, which in return have helped more patients get the benefit. Clay aims at reaching out to more people. He is excited about dealing with cancer patients because he has done it for more than 30 years.